BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

Insulin glargine, Quantity: 100 IU/mg

Disponible des:

Eli Lilly Australia Pty Ltd

Designació comuna internacional (DCI):

Insulin glargine

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: dilute hydrochloric acid; glycerol; sodium hydroxide; water for injections; metacresol; zinc oxide

Vía de administración:

Subcutaneous

Unidades en paquete:

2, 5, 10, 1

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for the control of hypeglycaemia.

Resumen del producto:

Visual Identification: Clear to colourless solution; Container Type: Cartridge; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-11-21